Skip to main content

Table 2 Description of inpatients with a FGM/C (n = 207) as primary or secondary diagnosis between 2016 and 2018 followed in one of four Swiss university hospitals (Geneva, Lausanne, Bern and Zürich)

From: Diagnoses and procedures of inpatients with female genital mutilation/cutting in Swiss University Hospitals: a cross-sectional study

Variables 2016 (n = 42) 2017 (n = 69) 2018 (n = 96)
Center, n (%)    
 Geneva 20 (47.6) 24 (34.8) 67 (69.8)
 Lausanne 13 (31.0) 10 (14.5) 19 (19.8)
 Bern 3 (7.1) 23 (33.3) 6 (6.3)
 Zürich 6 (14.3) 12 (17.4) 4 (4.2)
Country of origin, n (%)    
 Benin 0 (0) 0 (0) 1 (1.0)
 Burkina Faso 1 (2.4) 2 (2.9) 0 (0)
 Cameroon 1 (2.4) 0 (0) 0 (0)
 Côte d’Ivoire 1 (2.4) 1 (1.5) 1 (1.0)
 Egypt 0 (0) 0 (0) 5 (5.2)
 Eritrea 12 (28.6) 37 (53.6) 36 (37.5)
 Ethiopia 2 (4.8) 3 (4.4) 2 (2.1)
 Guinea 0 (0) 0 (0) 6 (6.2)
 Guinea-Bissau 0 (0) 0 (0) 2 (2.1)
 Mali 0 (0) 0 (0) 1 (1.0)
 Mauritania 0 (0) 0 (0) 1 (1.0)
 Nigeria 1 (2.4) 1 (1.5) 3 (3.1)
 Senegal 0 (0) 0 (0) 3 (3.1)
 Somalia 14 (33.3) 18 (26.1) 22 (22.9)
 Sudan and South Sudan 1 (2.4) 1 (1.5) 3 (3.1)
 Unknown or other 9 (21.4) 6 (8.7) 10 (10.4)
Service, n (%)    
 Gynaecology 13 (31.0) 12 (17.4) 9 (9.4)
 Gynaecology or obstetricsa 1 (2.4) 23 (33.3) 6 (6.3)
 Obstetrics 23 (54.8) 33 (47.8) 79 (82.3)
 Others 5 (11.9) 1 (1.5) 2 (2.1)
Mean age at first visit (± SD, median) 30.7 (± 12.0, 27) 27.7 (± 6.1, 27.4) 29.8 (± 6.7, 30)
FGM/C type, n (%)    
 Type I 3 (7.1) 13 (18.8) 10 (10.4)
 Type II 8 (19.1) 16 (23.2) 33 (34.4)
 Type III 21 (50.0) 33 (47.8) 39 (40.6)
 Type IV 0 (0) 1 (1.5) 2 (2.1)
 Unspecified or other 10 (23.8) 6 (8.7) 12 (12.5)
  1. aData obtained from Bern did not specify whether patients were admitted in gynecology or obstetrics